Automate Messaging Everywhere — Startups Get 12 Months Free
Promoted
Maker
📌
We're live today with CMD+RVL — the provenance and data lineage layer built specifically for investment teams. Your AI can spit out a $2.47B adjusted NAV in seconds… but when the partner, compliance team, or regulator asks “where did that number actually come from?”, most teams still spend days reconstructing the chain manually. CMD+RVL fixes that. It automatically traces every AI output back to its original sources (SEC EDGAR filings, FRED rates, etc.), documents every transformation, and delivers a clean, verifiable Provenance Receipt that holds up under scrutiny. Already tracing 138,000+ lineage connections, monitoring 1,185 deals, and providing full provenance on 7,385 charts. If you’re tired of “trust me bro” AI in finance and want defensible, audit-ready outputs instead — we’d love your feedback. Happy to answer any questions or jump on a quick call. What’s the biggest headache you face today when using AI for investment decisions? —The CMD+RVL team
Report
No reviews yetBe the first to leave a review for CMD+RVL
We're live today with CMD+RVL — the provenance and data lineage layer built specifically for investment teams.
Your AI can spit out a $2.47B adjusted NAV in seconds… but when the partner, compliance team, or regulator asks “where did that number actually come from?”, most teams still spend days reconstructing the chain manually.
CMD+RVL fixes that. It automatically traces every AI output back to its original sources (SEC EDGAR filings, FRED rates, etc.), documents every transformation, and delivers a clean, verifiable Provenance Receipt that holds up under scrutiny.
Already tracing 138,000+ lineage connections, monitoring 1,185 deals, and providing full provenance on 7,385 charts.
If you’re tired of “trust me bro” AI in finance and want defensible, audit-ready outputs instead — we’d love your feedback.
Happy to answer any questions or jump on a quick call. What’s the biggest headache you face today when using AI for investment decisions?
—The CMD+RVL team